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Available online 4 January 2010Dynamic causal modelling (DCM) of functional magnetic resonance imaging (fMRI) data offers new insights
into the pathophysiology of neurological disease and mechanisms of effective therapies. Current applications
can be used both to identify the most likely functional brain network underlying observed data and estimate
the networks' connectivity parameters. We examined the reproducibility of DCM in healthy subjects (young
18–48 years, n=27; old 50–80 years, n=15) in the context of action selection. We then examined the
effects of Parkinson's disease (50–78 years, Hoehn and Yahr stage 1–2.5, n=16) and dopaminergic therapy.
Forty-eight models were compared, for each of 90 sessions from 58 subjects. Model-evidences clustered
according to sets of structurally similar models, with high correlations over two sessions in healthy older
subjects. The same model was identiﬁed as most likely in healthy controls on both sessions and in medicated
patients. In this most likely network model, the selection of action was associated with enhanced coupling
between prefrontal cortex and the pre-supplementary motor area. However, the parameters for intrinsic
connectivity and contextual modulation in this model were poorly correlated across sessions. A different
model was identiﬁed in patients with Parkinson's disease after medication withdrawal. In “off” patients,
action selection was associated with enhanced connectivity from prefrontal to lateral premotor cortex. This
accords with independent evidence of a dopamine-dependent functional disconnection of the SMA in
Parkinson's disease. Together, these results suggest that DCM model selection is robust and sensitive enough
to study clinical populations and their pharmacological treatment. For critical inferences, model selection
may be sufﬁcient. However, caution is required when comparing groups or drug effects in terms of the
connectivity parameter estimates, if there are signiﬁcant posterior covariances among parameters.Cambridge, CB2 7EF, UK. Fax:
. Rowe).
license. © 2009 Elsevier Inc. Open access under CC BY license. Introduction
The advent of formal analytic methods to assess connectivity in
functional brain networks has enabled a much richer approach to the
understanding of the pathophysiology of disease, and the neurobio-
logical basis of effective therapies or recovery. These applications
include neurodevelopmental and neuropsychiatric disorders (Kim et
al., 2008; Stephan et al., 2006), healthy aging (Grady et al., 2003; Rowe
et al., 2006) neurodegenerative disease (Grafton et al., 1994; Rowe et
al., 2002b; Sonty et al., 2007) and real or simulated focal lesions
(Grefkes et al., 2008; Kim and Horwitz, 2009; Rowe et al., 2007;
Sharma et al., 2009). Indeed, these studies have often observed that
measures of network connectivity are more sensitive to pathophys-
iology or treatment than standard analysis of regional activations.Increasing applications of these methods in clinical and non-clinical
settings are therefore likely.
Dynamic causal modelling (DCM) has aroused particular interest
since its introduction, in part because of the underlying Bayesian
framework that permits model comparison among both nested and
non-nested models (Friston et al., 2003; Penny et al., 2004a; Stephan
et al., 2009a). The advantages of DCM have been discussed elsewhere
(Penny et al., 2004b) with some direct empirical comparisons with
othermethods (Passamonti et al., 2008). However, future applications
to clinical and pharmacological studies will be strengthened by
information about the ability of DCM to re-identify evidence based
network models as well as the ability to replicate model parameters
(Schuyler et al., 2009).
In this paper, we address several issues that are critical if DCM is
used to study clinical states or the effects of pharmacological
interventions on network connectivity. In particular, (1) do DCM
based model comparison procedures re-identify the same network
model as “most likely” given evidence from data acquired in different
sessions from the same individuals? Stability of model selectionmight
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factors like varying signal to noise and the BOLD signal. These factors
are also important for classical analysis of regional activations across
different sessions, including pharmacological fMRI (Iannetti andWise,
2007; Lund et al., 2005; McGonigle et al., 2000). (2) Does DCM model
selection identify differences in the network dynamics of a patient
group? If so, does this support independent evidence for dysfunction
of one or more elements of that network? While DCM will give new
insights into network dynamics, there are areas of potential
concordance between DCM and other methods such as analysis of
regional activations, which could be identiﬁed. (3) Within the
selected network model, does the application of DCM to data across
different sessions replicate the parameter estimates for intrinsic
connectivity and modulatory effects of the task context as expressed
by the bilinear terms? Evidence of replication within-subjects across-
sessions would support the use of DCM to explore between group
differences in terms of connectivity parameters. Preliminary results
are encouraging with high reliability in simplemodels (Schuyler et al.,
2009). (4) Finally, is DCM sensitive to an effective intervention, such
as an established pharmacological treatment in a deﬁned clinical
population?
To answer these questions empirically, we assessed DCM in the
context of action selection (Rowe et al., 2005) by young and older
healthy adults and older adults with the common neurodegenerative
movement disorder, Parkinson's disease. We chose the action-
selection paradigm because it gives robust fMRI activations of a
reproducible set of distributed cortical activations in diverse popula-
tions (Deiber et al., 1991; Forstmann et al., 2008; Rowe et al., 2008a,
2005). Moreover, the paradigm is prima facie relevant to Parkinson's
disease. In addition, there is an established literature with other
methods to assess effective connectivity in the motor system with
Parkinson's disease, including structural equation modelling (SEM) of
fMRI (Palmer et al., 2009; Rowe et al., 2002b), path analysis of
positron emission tomography data (Grafton et al., 1994) and
regression models for fMRI embodying psychophysiological interac-
tions (PPI) (Helmich et al., 2009, 2007).
Studies of Parkinson's disease using analyses of connectivity (SEM,
PPI) or regional activations (voxelwise general linear models) have
suggested a shift away from a medial route to voluntary action (from
prefrontal cortex via pre-SMA and SMA to motor cortex) towards a
lateral route (via lateral premotor cortex). This is partly driven by
primary dysfunction of the supplementarymotor area (SMA) and pre-
SMA (Haslinger et al., 2001; Jahanshahi et al., 1995; Playford et al.,
1992; Sabatini et al., 2000; Samuel et al., 1997; Yu et al., 2007) or a
functional disconnection of the SMA (Rowe et al., 2002b), with
compensatory enhancement of lateral premotor systems (the deﬁcit
driving the shift may be downstream of the dysfunctional nigrostriatal
pathway output to the cortex via the thalamus, or reﬂect changes
intrinsic to the SMA/pre-SMA). Moreover, this dysfunction of the pre-
SMA and SMA is responsive to dopaminergic therapy (Buhmann et al.,
2003; Haslinger et al., 2001; Jenkins et al., 1992; Rascol et al., 1994)
and accentuated for self-generated or chosen actions, in comparison
with speciﬁed or cued actions. This disease and therapeutic model is
therefore well suited to test the performance of DCM, provided that
good practice recommendations are adhered to (Stephan et al.,
2009b).
Our ﬁrst hypothesis was that DCM is replicable across sessions. We
took a hierarchical approach, ﬁrst considering the replication of model
selection and then the reliability of parameter estimates within the
most likely model. Through systematic variations on a prior structural
model, we tested secondary hypotheses about feed-forward and feed-
back connections; direct and modulatory effects of task manipula-
tions; and the likely site of task related changes in effective
connectivity. We also predicted that DCM can identify changes in
motor networks in Parkinson's disease that reﬂect a shift away from
the medial route to action (via SMA and pre-SMA) towards a lateralroute (via lateral premotor cortex) for voluntary action. Finally, we
predicted that this connectivity change in PD is sensitive to
dopaminergic therapy.
Methods
Subjects and task
Sixteen patients (PD, 50–80 years) with idiopathic Parkinson's
disease were recruited from the Cambridge Centre for Brain Repair's
PD research clinic, using the UK PD Brain Bank clinical diagnostic
criteria. Patients were tested once after their usual dopaminergic
medication and once after dopaminergic mediation had been
withdrawn (minimum 12 h for short acting preparations, 24 h for
long acting preparations such as modiﬁed/slow-release preparations
of L-dopa and carbergoline). The order of “on” vs. “off” sessions was
randomly permuted within blocks of six successive subjects. Patients
were examined on both occasions using the UPDRS-III motor rating
scale (Fahn et al., 1987) and staged with the Hoehn and Yahr scale
(Hoehn and Yahr, 1967).
Fifteen healthy older controls subjects (OC, 50–80 years) and
twenty-eight healthy younger adults (18 to 48 years) were recruited
from the PD research clinic database and the volunteer panel of the
MRC Cognition and Brain Sciences Unit. Older subjects participated
twice in the study, and their two sessions were randomly assigned to
sessions A and B, similar to patient assignment to ‘on’ vs. ‘off’ sessions.
The younger subjects participated once only. All subjects were right
handed with no current depressive illness, no dementia based on
prior cognitive assessment and no signiﬁcant neurological (except
Parkinson's disease) or psychiatric illness. The study was given a
favourable opinion by the local Research Ethics Committee and
participants gave written informed consent according to the 1991
Declaration of Helsinki. Subject details are summarised in supple-
mentary Table S1.
A simple ﬁnger-tapping task used visually paced right hand button
presses, in which subjects were presentedwith a picture of a right hand
and pressed a button with one of their four right hand ﬁngers in
response to a cue. A small empty circlewas presented above eachﬁnger.
Half of responses were “speciﬁed,” by a single circle changing colour to
black for 1 s, indicating which ﬁnger to press. Half of responses were
“chosen,” indicated by all four circles changing to black for 1 s during
which subjects could choose which of the four ﬁngers to press. For this
condition subjects were asked to make a “fresh choice on each trial
regardless of what you have pressed before.” Thismight ideally lead one
to make random choices. However, they were speciﬁcally not asked to
make random selections as this can paradoxically invoke very non-
random choices. Subjects made 40 speciﬁed responses and 40 chosen
responses, interspersed with 40 null events (no change of colour in the
circles above each ﬁnger, appearing to the subjects the same as the
interstimulus interval cue). Cues were presented for 1 s with a stimulus
onset asynchrony of 2.5 s, randomly intermixed, under control from
Cogent 2000 software (www.vislab.ucl.ac.uk/Cogent2000) using
Matlab 7.1 (www.mathworks.com) in Windows XP (www.microsoft.
com).
MRI data acquisition and analysis of regional activations
A Siemens Tim Trio 3 Tesla scanner was used to acquire BOLD
sensitive T2⁎ weighted EPI images (TR 2000 ms, TE 30 ms, FA 78
degrees) with 32 slices, 3.0 mm thick, in-plane resolution 3×3 mm,
with slice separation 0.75 mm, in sequential descending order. 156
volumes were acquired, the ﬁrst 6 of which were discarded to allow
for steady-state magnetisation. An MPRAGE T1-weighted structural
image was also acquired for each subject (TR 2250 ms, TE 2.99 ms, FA
9 degrees, IT 900 ms, 256×256×192 isotropic 1 mm voxels).
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ucl.ac.uk /spm) in Matlab 7.1 (R14, Mathworks, CA). fMRI data were
converted from DICOM to NIFTII format, spatially realigned to the ﬁrst
image and sinc interpolated in time to the middle slice time to correct
for acquisition delay. The mean fMRI volume and MPRAGE were
coregistered using mutual information, and the MPRAGE segmented
and normalised to the Montreal Neurological Institute T1 template in
SPM by linear and non-linear deformations. The normalisation
parameters were then applied to all spatiotemporally realigned
functional images, the mean image and structural images, prior to
spatial smoothing of fMRI data with an isotropic Gaussian kernel
FWHM 10 mm.
First level Statistical Parametric Modelling for each subject used a
general linear model with one regressor representing the presenta-
tion of a trial (of any type), subject to parametric modulation
according to the two conditions “speciﬁed” and “chosen,” and also
to reaction time. Additional subject speciﬁc regressors were included
for scans which exceeded threshold for scan to scan movement or
variance. This removes the effect of that scan on estimation or
parameters for effects of interest (“nulling scans”) (Lemieux et al.,
2007; Rowe et al., 2008b,c). A second level model (random effects)
was made for each contrast of interest using an ANOVA of the contrast
images from each older subject at the ﬁrst level (patient and older
controls). Second level contrasts included “Task,” collapsing “chosen”
and “speciﬁed trials,” and “Selection,” contrasting chosen with
speciﬁed actions. The second level model was a pseudofactorial
design with group as a between subjects factor (control vs. patient)
and treatment as a within subject factor (patients: dopaminergic
treatment vs. dopaminergic withdrawal; controls: random assign-
ment of the 2 sessions in the same procedure as randomisation of the
order of patient treatment but for controls no medication was given).
Dynamic causal modelling
The DCM proceeded with the following schema: (1) deﬁne an
anatomical network of contributory regions, (2) deﬁne a set of models
based on variations of intrinsic connections within this network,
principally by specifying unidirectional or bidirectional connectivity
(see Fig. 1), (3) specify bilinear terms, indicating the modulatory
effect of task type (chosen vs. speciﬁed trials), (4) specify direct inputs
to prefrontal cortex, that in every model was the onset of the go
stimulus, and in a subset of models also the task type (chosen vs.
speciﬁed), (5) extract BOLD fMRI time series from the network
regions for each subject, (6) estimate the models, (7) compare all
models using the free energy estimate of the model evidence,
grouping according to age, disease or treatment, (8) compare the
leading models, in terms of relevant between-subjects factors, using
ﬁxed and random effects methods described below.
The anatomical network model of frontal cortical motor interac-
tions was based on our previous model for structural equation
modelling of action in Parkinson's disease (Rowe et al., 2002b). It
included left dorsolateral prefrontal cortex (PFC), left lateral premotor
cortex (PM), pre-supplementary motor area (pre-SMA) and left
primary motor cortex (M1). The coordinates of these regions were
based on local peaks in the second level model of regional activations
(see supplementary Table S2) BOLD fMRI time series were extracted
from regions 10mm in diameter centred on these locations, from each
subject, using the ﬁrst eigenvariate of voxels above a subject speciﬁc
F-threshold of pb0.001 (uncorrected). Where a subject had no voxel
above threshold at the speciﬁed location, the centre of the ROI was
adjusted to the nearest suprathreshold voxel, and checked to ensure
that it lay within an appropriate anatomical range, for example, that
the motor cortical region of interest lay on the precentral bank of the
central sulcus. Table S2 shows the second level contrast coordinates,
and the mean of actual coordinates used by all subjects as the centres
of regions for time series extraction.The connections between these regions were speciﬁed as intrinsic
connections (matrix A in DCM) as shown in Fig. 1. The initiation of an
action, whether speciﬁed or chosen, was modelled as a task input to
prefrontal cortex (matrix C in DCM). This reﬂected the rostro-caudal
sequence of frontal cortical activation in neurophysiological measure-
ments of cued manual actions (Nishitani and Hari, 2000; Pedersen
et al., 1998). DCM enables the comparison of non-nested models for
the same data. We therefore speciﬁed 48 variations on this model,
based on the presence of unidirectional (Fig. 1 model sets A and B) or
bidirectional connections between these cortical regions (Fig. 1 model
sets C–F).
The difference between the two conditions (chosen vs. speciﬁed)
may manifest itself through changes in cortico-cortical connectivity,
constituting a psychophysiological interaction (PPI) (Friston et al.,
1997). Here, the context of chosen versus speciﬁed actions is
proposed to be mediated by a change in the intrinsic connectivity of
the motor network, consequent to transient perturbation of that
network by the stimulus. Such psychophysiological interactions are
implemented as bilinear terms in DCM (matrix B) (Friston et al., 2003;
Penny et al., 2004a), in contrast to the moderator variables in
structural equation models (Rowe et al., 2002a,b, 2005) or interaction
regressors in general linear models of PPIs.
The set of models varied systematically in terms of the connections
which were subject to contextual modulation. For example, was the
difference between trial types manifest as differences in connectivity
between PFC and PMC or between PFC and pre-SMA? See Fig. 1 for the
full set of models. In general, the model sets included modulation
of each connection separately (Fig. 1 model sets 1–4), or rostral con-
nections (Fig. 1 model set 5), caudal connections (Fig. 1 model set 6),
both rostral and caudal connections and all connections including
between premotor cortex and pre-SMA (Fig. 1 model sets 7 and 8).
These patterns of modulation were applied to rostro-caudal and
reciprocal connections when these existed in the model. In addition,
the difference between selection and speciﬁed conditions was included
as a direct inﬂuence on prefrontal cortex in a subset of models (Fig. 1,
model sets B, D, and F).
The dynamic causal model was implemented for each session, for
each subject, for each model (4320 in total). Each model was ﬁtted by
SPM5, with expectation maximisation procedure for estimation of the
parameters of intrinsic, bilinear and input connections, and the
parameters of the biophysical model of the evoked haemodynamic
response to neural activation (Friston et al., 2003).
In addition to the model speciﬁc estimates of the connection
parameters, each estimation procedure also derives an estimated
bound on the model evidence, using the free-energy criterion, F
(Friston et al., 2007). This free-energy criterion indicates the accuracy
of themodel (as log-likelihoodof the data) corrected for the complexity
of the model. The complexity term depends on both the number of
parameters and the dependencies between parameters. Unlike
previous approximations of the model evidence, such as Akaike's
information criterion and Bayes' information criterion (Penny et al.,
2004a), the free-energy estimate adjusts the penalty for model
complexity according to both a priori and a posteriori independence
of the model parameters. We therefore used the negative free energy
estimates to compare models within and between subjects.
The negative free energy estimate can be summed over subjects
for each model to estimate the cumulative evidence for that group of
subjects, comparable to the use of Group Bayes factors, This approach
has been used for fMRI (Acs and Greenlee, 2008; Allen et al., 2008 ;
Grol et al., 2007; Heim et al., 2009; Kumar et al., 2007; Leff et al., 2008;
Smith et al., 2006; Stephan et al., 2007a,b; Summerﬁeld and Koechlin,
2008) and EEG data (Garrido et al., 2008, 2009, 2007). This approach is
also termed a ﬁxed effects method, because it assumes that all
members of the groups generated data from the same underlying
model, without the model itself being a random variable between
subjects.
Fig. 1. Schematic representations of the 48 models compared in this study. Models are illustrated in sets, grouped by intrinsic connectivity structure (letters A–F) and by the
modulation of connectivity by the difference between chosen and speciﬁed conditions (numbers 1–8). Models E1 and E2 are enlarged. The free energy estimate of the log evidence, F,
is greatest for model E2 in young and old healthy subjects, and patients on dopaminergic therapy. Model E1 is more likely in patients in a relative “off” state induced by medication
withdrawal. The models differ in the contextual modulation of task related connectivity, which is manifest in changing connectivity of prefrontal to pre-SMA connectivity (E2) or
prefrontal to premotor cortex connectivity (E1). PFC=prefrontal cortex, pre-SMA=pre-supplementary motor area, PM=premotor cortex, M1=primary motor cortex. For clarity,
the labels are omitted from the small model illustrations. The contextual modulation is illustrated by a dotted arrow.
1018 J.B. Rowe et al. / NeuroImage 52 (2010) 1015–1026We undertook several approaches to assess the reproducibility of
DCM model selection. First, we asked whether the most likely model
over all healthy subjects is also separately identiﬁed in two separate
groups of healthy adults. Second, we assessed whether the samemodel
is identiﬁed from a group of subjects when the same experiment is
repeated on two separate sessions. For this, we present the model
rankings based on the group sum of log-evidence (F) (Fig. 2).
The selection of one or other model as most likely depends on the
difference in log-evidence, which can also be expressed in terms of the
Bayes factor. Given models A and B, the Bayes factor (BF) comparing
model A to model B is deﬁned as the ratio of model evidences (Kass
and Raftery, 1995; Raftery, 1995) such that the log-BF corresponds to
the difference in log-evidences. By convention (Raftery, 1995) BF in
the range 3–20 indicates positive evidence for model A over B; BF in
the range 20–150 indicates strong evidence; and BF N150 indicates
very strong evidence. The equivalent thresholds for differences in log-evidences are 1.1–3, 3–5 and N5 respectively. The approach enables
the comparison of non-nested models (Fig. 2D).
Stephan et al. (2009a,b) have recently shown that model selection
methods that adopt a ﬁxed effects model (using Group Bayes Factors
of sum of group log-evidences as above) can be adversely affected by
outliers (Stephan et al., 2009a). They introduced a hierarchical
Bayesian model selection procedure which accommodates group
heterogeneity, estimating the probabilities of a set of models (with a
Dirichlet distribution) and the probability of a subject's data given
each model. This does not assume that all subjects in a group
generated their data according to the same model.
The hierarchical Bayesian model selection approach is equivalent
to a random effects analysis incorporating between subject differ-
ences in the probability of model having generated the group data. For
the current study, this procedure was implemented within SPM8,
using initially all 48 models, then repeated using the three most likely
Fig. 2. (A) For all healthy subjects the difference in log-evidence, estimated by the free energy F for eachmodel, is plotted against the number of user speciﬁed connection parameters
in the models. For each set of structural models (labelled A–F, according to Fig. 1) there are further differences in F according to the bilinear effects representing contextual
modulation of connectivity. The most likely model of all E2 is referenced at F=0. (B) The log-evidence estimate F is plotted against the model rank over all healthy subjects, from
least likely=1 to most likely=48. (C) The 48 model evidences summed over 15 elderly control subjects on each of two sessions A and B, indicating a strong positive correlation.
Evidences are plotted relative to the most likely model, E2. (D) The group differences in log-evidence estimates F for models E1 and C2 are plotted relative to the overall preferred
model E2. Bars represent the difference between models, for each group by session. For older control subjects (OC) the two sessions were randomly assigned to sessions A and B,
matched for ﬁrst and second sessions. Similarly, for patients with PD, one session was in a relative “off” state induced by medication withdrawal, while the other session was in a
relative “on” state with usual medication. Horizontal lines indicate thresholds for positive evidence (dotted) or strong evidence (dashed) in favour of model E2 (if below the line) or
against model E2 (if above the line).
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repeated for healthy older controls and PD patients “on” and “off”
medication.
Results of this Bayesian model selection procedure for a group can
be presented as (a) the expected likelihood of obtaining a givenmodel
for any randomly selected subject in the group, or (b) the exceedance
probability, which is the belief that a particular model is more likely
than any other model (of all models tested), given the group data.
Both indices are based on the parameters of the Dirichlet distribution
of the models themselves, and therefore the model rankings are the
same for both presentations. Both indices sum to one, over all models
compared, and may show that one model is more likely for the group
data, incorporating the distribution of model probabilities across the
group.
Having identiﬁed the most likely model, we then explored the
parameters within that optimal model, using parametric and non-
parametric classical (frequentist) statistics. The use of parametric
statistics to assess model parameters has been made in previous DCM
studies of condition or groups effects but the values may violate the
assumptions of normal distributions, and non-parametric methods
are therefore also used. The parameters we examined included the
connection weights for intrinsic connectivity (matrix A); the
connection weights for the bilinear terms expressing the psycho-
physiological interactions (matrix B); the connection weights for
direct inputs (matrix C), and the ratio of the bilinear term to theintrinsic connection weight (ratio B/A, for non-zero B). Using these
values, we compared (1) young vs. older healthy groups, (2) older
subjects during sessions, randomly assigned to session A and session B
to counterbalance order, rather than ﬁrst and second session, (3)
older subjects vs. patientswith PD, (4) patients with PD, “on” and “off”
their dopaminergic medication.
As the parameter estimates were not reliable across sessions, we
explored the posterior covariances among parameters for intrinsic
connections (DCM.A matrix), bilinear terms (DCM.B matrix) and the
driving input (DCM.C matrix). We normalised the posterior covari-
ance matrices (output matrix DCM.Cp) for each subject/group/
session to get correlation matrices for ease of interpretation. We
calculated the “group×session” mean correlations for each pair-wise
combination of intrinsic connectivity, bilinear term and driving input.
For healthy older control subjects we performed 1-sample t-tests
across the group to test the null hypothesis that the correlations had
zero mean, and Bonferroni corrected for multiple comparisons. For
the pair-wise correlations among A, B and C matrix parameters, we
then correlated these group mean values from two sessions
performed by the healthy older controls. Finally, the posterior
correlations were in turn compared with the between-sessions
reliability of each parameter estimate, to test the hypothesis that
greater posterior correlations among parameters would reduce the
identiﬁability and reliability of parameter estimation, and thereby
reduce between-sessions correlation of a given parameter.
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Model selection (ﬁxed effects)
The distribution of log evidences across all models for all healthy
subjects is shown in Fig. 2, according to the number of user speciﬁed
connection parameters, including intrinsic and bilinear terms (Fig.
2A) and the rank of the models (Fig. 2B, from most likely to least
likely). It can be seen that models fall into groups, according to model
structure, comparing Figs. 2 and 1. Within each group, the addition of
more terms, increasing model complexity, does in itself increase the
evidence for a model (no positive correlation between F and number
of parameters). Indeed, the more likely models (E2, E1, C2) are among
the simpler models within each set.
Model E2 emerges as the most likely of the 48 models, in healthy
subjects. Model C2 is second, and model E1 is third, but the difference
in log-evidences, ΔF, are−2.64 and−3.4 respectively, indicating that
there is strong evidence in favour of model E2. There is very strong
evidence (ΔFN5, BFN150) for these three models ahead of the fourth
and subsequent models.
In Fig. 2c, one can see the strong positive correlation between the
log-evidences F across two sessions (spearman rho=0.96, n=48,
pb0.001) indicating that a model that is more likely on one session in
healthy controls is also more likely on another session for the same
subjects performing the same paradigm. However, many of these
models are very unlikely.
Focussing on the three leading models from the whole group of
healthy controls, C2, E1 and E2, we now consider the question of re-
identiﬁcation of models, and sensitivity to disease and therapy. Fig. 2D
shows the relative differences between models in different sessions
within each group. For healthy control subjects, model E2 is the most
likely model on both sessions, but there is a variable level of evidenceFig. 3. Random effects and ﬁxed effects approaches to group model selection. For a ﬁxed e
compared using (A) the sum of log-evidences (cf. the Group Bayes Factor for the model) or (B
analysis are E2NC2NE1. A random effects analysis using a hierarchical Bayesian model selec
expected posterior probability that a given subject had generated data according to a given m
is more likely than any other model.that model E2 is superior. For example, there is positive evidence that
E2 is a better model than E1 in both sessions of healthy controls.
However, model C2 is not sufﬁciently worse than E2 to pass the
conventional threshold indicating positive evidence in favour of E2.
From session A alone in healthy controls, the data do not provide
positive or strong evidence that E2 is superior.
Session differences are also clearly seen in the patients, but this
session difference is characterised by withdrawal of dopaminergic
medication. Whether patients are “on” or “off” medication, model E2
is more likely than model C2. When on medication, model E2 remains
more likely than model E1, as for healthy subjects. However,
withdrawal of dopaminergic medication leads to a change in the
most likely network model, from E2 to E1. The difference between
these models is that the bilinear term, expressing the modulation of
connectivity under different task conditions, affects interactions
between prefrontal and premotor cortex rather than prefrontal cortex
and pre-SMA (see Fig. 1 models E1 and E2).
Bayesian model selection (random effects)
Among healthy controls, the random effects method of Bayesian
model selection again identiﬁed model E2 as most likely. A
comparison of the ﬁxed effects and random effects approaches is
shown in Figs. 3 and 4. The results ﬁrst conﬁrm the clustering of
models in to families of structural similarity. For the three more likely
models (E2, E1, C2) the random effects and ﬁxed effects approaches
produce similar rankings, but the differences between models are
easily appreciated with the random effects approach. Considering the
three most likely models in Fig. 4, for any given healthy subject, one
would be ∼57% likely to identifymodel E2 as the generator of the data,
and for the group as a whole, one is 90% conﬁdent that E2 is the most
likely model that generated subjects' data.ffects analysis of the 48 models (in six sets A to F, see also Fig. 1) the models can be
) the equivalent posterior model probability. The leading three models from the groups
tion procedure (see Methods) over all 48 models compares models in terms of (C) the
odel or (D) the exceedance probability representing the conﬁdence that a given model
1021J.B. Rowe et al. / NeuroImage 52 (2010) 1015–1026For patients “on” medication, the group ﬁxed effects and random
effects results of model selection are shown in Fig. 4. Again model E2
was most likely to have generated the data for the group, using both
random and ﬁxed effects methods. However, the two methods of
model selection differ in ranking the next models. The random effects
models suggest that model E1 was second most likely to have
generated the data for “on” PD patients. The difference may be
explained in terms of a subset of PD “on” patients with features of PD
“off” patients (see next paragraph). This subset did not have
sufﬁciently marked model evidences individually to inﬂuence the
ﬁxed effects analysis (in which model E1 was much less likely). An
alternative interpretation is that a subset of PD “on” patients were
characterised by normal behaviours, with strong individual model
evidences, increasing the similarity of the ﬁxed effects analysis for PD
“on” and health aged controls.
Patients in a relative “off” state after medication withdrawal are
qualitatively different. As shown in Fig. 4, it wasmore likely thatmodel
E1 generated their data, a model in which selection to action is
associated with increased coupling between prefrontal cortex and
lateral premotor regions but notpre-SMA.Here, bothﬁxed and random
effects methods were concordant, providing N90% posterior model
probability or N95% exceedance probability in favour of model E1.
Parameter estimation
Theeffect of direct trial input to theprefrontal cortex (the ‘injection’
of perturbation into the network, DCM matrix C) was positive in all
groups (older subjects mean 0.10 Hz SE 0.02, younger subjects mean
0.09 Hz SE 0.02). Values from the older subjects were entered into a
2×2 repeatedmeasures ANOVA (factor 1: group, Older controls vs. PD
patients; factor 2 drug treatment/session) which indicated no
differences between groups or sessions, or groupby session interaction
(all F(1,14)b1, ns). This implies that neither PD nor dopaminergic
medication alters the parameter estimate for the driving input.
There were bidirectional intrinsic connections between nodes in
the most likely model E2 (ten intrinsic connections, DCM matrix A).
These were entered into a 10×2×2 repeated measures ANOVA
(factor 1: group, Older controls vs. PD patients; factor 2 drug
treatment/session; factor 3 connection). There was evidence of
strong differences in intrinsic connectivity for the different connec-
tions (F(9,117)=24, pb0.001) but no group difference (F(1,13)=2.9,
ns) or any other main effect, 2-way and 3-way interactions (Fb1.4,
ns). Thus, the intrinsic parameters are not signiﬁcantly different
between groups, and none of the connections was consistently higher
or lower on different sessions, even when the sessions were
associated with drug differences in the PD group.
For healthy control subjects, the correlation between intrinsic
parameters across two sessions was also not high e.g. for the
PFC→pre-SMA connection, r2=0.02 (see Fig. 5A, ns), with other
connections ranging r2 between 0.0 and 0.13. For PD patients
however, correlations were higher, e.g. for PFC→pre-SMA r2=0.41
(see Fig. 5B, n=16, pb0.01), with other connections varying in terms
of r2, between 0.04 and 0.26 (all ns) except for SMA→MC (r2=0.48,
pb0.01) and pre-SMA→PM (r2=0.39, pb0.05). Despite these low
correlations in the value of the intrinsic connectivity parameters, the
sign or direction of effect is well preserved i.e. a positive connection
on one session remains positive on a second occasion. For ﬁve of ten
intrinsic connections, no subject altered sign. For one connection the
sign was reversed in one subject only. For the four other intrinsic
connections, four or ﬁve out of 15 subjects changed sign between the
two sessions and one cannot therefore reject the null hypothesis of
random sign for these connections (PFC→PM, PFC→pre-SMA,
PM→PFC, pre-SMA→PFC; chi-squared 1.7–3.3, df 1, ns).
The bilinear terms are generally themain interest in DCM studies of
effective connectivity, expressing a psychophysiological interaction.
Thepreferredmodel E2 includedbilinearmodulation of connectivity ofPFC→pre-SMA (mean of older subjects=0.06, SE=0.01) and vice
versa (mean of older subjects=0.05, SE=0.01). The values of the
bilinear term fromeach subject and sessionwas entered into a 2×2×2
repeated measures ANOVA (factor 1: group, Older controls vs. PD
patients; factor 2 drug treatment/session; factor 3 connection,
PFC→pre-SMA vs. pre-SMA→PFC). All main effects, 2-way and 3-
way interactions were clearly negative (F(1,14)b1, ns) except for the
weak effect for a group by drug interaction (F(1,14)=2.2, p=0.13).
One-sample Kolmogorov–Smirnov tests of the distribution of para-
meters for each of the two connections for each drug and group (8
tests, K-S zb1,N=15 or 16, each ns) or for the two connections pooled
over all older subjects-sessions (2 tests: K-S zb1.3,N=62, both ns) did
not reveal any signiﬁcant deviations from normality.
The bilinear terms expressing contextual modulation (chosen vs.
speciﬁed) of response correlated weakly across healthy older subjects
between sessions for the modulation of PFC→pre-SMA connectivity,
Pearson r2=0.17, n=15, p=0.06, although non-parametric Spear-
man rho did reach signiﬁcance threshold (see Fig. 5C–D, rho=0.504,
n=15, p=0.03). Similar between sessions correlations for this
connection were seen for PD patients (Fig. 5D). For the reverse
connection, pre-SMA→PFC, the correlation was not signiﬁcant
(r2=0.01, n=15, ns; rho=0.02).
One may be more interested in the sign of a psychophysiological
interaction than its magnitude i.e. does the context increase or
decrease connectivity? In healthy controls, 11/15 subjects had the
same sign on both sessions, and one cannot reject the null hypothesis
that the direction of effect is not preserved over repeat sessions (chi-
squared=3.3, df 1, p=0.07). Among patients, 11/16 subjects
maintained sign and for this group (with drug treatment) one cannot
reject the null hypothesis that the direction of effect is not preserved
over repeat sessions with drug withdrawal (chi-squared 2.3, df 1, ns).
Posterior covariances and identiﬁability of parameters
One of the factors that determine the reliability of parameter
estimation is identiﬁability of parameters. Pronounced posterior
covariances among parameters, indicating inter-dependencies, make
the parameters difﬁcult to identify (Deneux and Faugeras, 2006;
Stephan et al., 2009b, 2007b). In our optimal model E2, and the
nearest models E1 and C2, there were signiﬁcant posterior covar-
iances among the parameters for intrinsic, bilinear and driving inputs.
We have normalised these values (from the output DCM.Cp) and
illustrate them in Fig. 6 for model E2.
In both healthy older controls (Fig. 6A) and patients with PD
(Fig. 6B) there are similar patterns of posterior correlations. The
majority of correlations were negative (61/78=78%). Although the
correlations are generally small (most less than ±0.1, with a few up
to −0.3) they are numerous and highly consistent for this model
(Figs. 6C, D) both within a session and between sessions.
We looked for a correlation between the inter-session correlations
of intrinsic parameters between two sessions, and the posterior
correlations among connections. It was predicted that for any given
connection, higher maximal posterior correlations or higher sum of
posterior correlations (real or absolute) would themselves correlate
negatively with the intersession reliability of the connection's
parameter estimate. For older controls, no such relationship was
found (all rb0.15, pN0.1). This negative result is perhaps because a
different subset of posterior correlations was relevant, or because of
complex interactions among them.
Discussion
Model selection and parameter estimation
Our results provide clear evidence that a DCM model selection
procedures are able to re-identify the most likely model from a group
Fig. 4. Random effects and Fixed effects Bayesian Model Selection approaches to group model selection for Healthy older controls, PD patients “on” and PD patients “off,” for the leading models E2, E1 and C2. Fixed effects analyses results are
presented as log-evidences and Posterior Model Probability (PMP). Random effects analyses are presented as Expected Posterior Probability (EPP) or Exceedance Probabilities (ExPr). It can be seen that by both approaches, model E2 is
preferred in Healthy Controls and PD “on” patients, but that model E1 is preferred in PD “off” patients. The difference between ﬁxed and random effects models is seen for PD “on” patients, for whom model E1 is second most likely by the
random effects method, but very unlikely by the ﬁxed effects method.
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Fig. 5. The estimates of intrinsic connectivity PFC→pre-SMA across two sessions was poorly correlated in healthy older controls (OC, panel A) but positively correlated in patients
with Parkinson's disease (PD, panel B). The estimate of the bilinear term in older healthy control subjects (C) and PD patients (D), each group repeating the same paradigm on two
occasions. These estimates of the bilinear term express the modulation of PFC→pre-SMA connectivity by trial context (chosen vs. speciﬁed response trials). The parametric
correlations are not signiﬁcant, but see also Results for non-parametric statistics.
Fig. 6. Theposterior covariances amongparameter estimates (outputmatrix DCM.Cp) have been normalised to correlationmatrices, and averagedacross healthyolder control subjects (A)
andpatientswithPD(B). Thematrices show thegroupaveragedposterior correlationsamong intrinsic connections representedby theDCM.Amatrix “A,” the twobilineareffects fromDCM.
B “B” and the direct driving inputs fromDCM.C “C.” At a glance, one can see the prevalence of non-zero correlations between connectivity parameters, and the similarity of these posterior
covariances in the two groups. (C) The map of t-statistics from 2-tailed one-sample t-tests at each element of the posterior correlation matrix for healthy subjects. The absolute values of
correlations in panels (A) and (B) were small (typically less than±0.1 and all less than ±0.3) but these interdependencies are signiﬁcantly different from zero across the group (C). The
asterisk indicates t-threshold for signiﬁcance (pb0.05, Bonferroni corrected formultiple tests). In panel (D)we show that the averaged values in the posterior correlationsmatrices from a
group of older healthy subjects are reproduced on two sessions for the preferred model (E2) (Spearmans' rho=0.99) and that these values are mostly negative (61/78=78%).
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model was also most likely when considering the evidence over a
larger group of old and young healthy adults. When each session was
considered separately, there was not sufﬁcient evidence to select the
most likely model (E2) over a second model (C2). However, model C2
was nested within model E2, differing only by the modulation of the
feedback as well as feedforward connections. These two models were
similar to each other and signiﬁcantly separated in terms of model-
evidence from all other models. For identiﬁcation of the most likely
model (E2), both ﬁxed and random effects modelling of the group
data were concordant for healthy subjects and “on” PD patients.
Importantly for the future application of DCM to clinical and
pharmacological studies, DCMmodel selection did identify a different
model (E1) as most likely in patients “off” mediation. Model E1 was
more likely than any other model in “off” patients, while the normal
model E2 was more likely in patients “on” medication. For some
studies, exploring the effects of disease or drug on network
connectivity, it would be sufﬁcient to stop at this stage of model
selection, with strong evidence for the inference that the disease or
drug therapy had changed network connectivity from one pattern to
another.
In our paradigm and groups, it is noteworthy that the DCM model
selection conﬁrms a shift in the causal interactions underlying
response selection, away from amedial prefrontal-SMA route towards
a lateral prefrontal-premotor. This accords with the earlier evidence
of a functional deafferentation of the pre-SMA and SMA (Dick et al.,
1986; Rowe et al., 2002b) and a greater role for lateral premotor
cortex in patients making complex ﬁnger movements (Samuel et al.,
1997).
Although it may be sufﬁcient to stop with evidence of alternative
network models, it is common practice to analyse the parameter
estimates within these models. This is often motivated by the aims of
scientiﬁc transparency and artefact detection, as well as the theoretical
importance of parameter estimates for some research questions
(Summerﬁeld et al., 2006). In addition, secondary analysis of parameter
estimates using frequentist methods like t-tests or ANOVA have been
used to compare groups, or correlate with between-subject measures
(Passamonti et al., 2008; Sonty et al., 2007). This is appropriate for group
studies with some caveats (Stephan et al., 2009b) and it is possible
therefore to use connectivity parameters to compare two groups or to
compare connectivity under two therapeutic conditions.
Our results suggest caution when using this parameter based
approach, at least for some models. Whereas Schuyler et al. (2009)
found excellent reliability across sessions for DCM connectivity
parameters, this was not the case for the preferred model in the
current study. Althoughmany intrinsic connections didmaintain their
sign over two sessions in all subjects, four out of ten intrinsic
connections changed sign in a third of healthy participants, when a
priori no change would be expected. Parametric correlations were
poor for intrinsic connections and bilinear terms across sessions in
healthy subjects.
For patients, signiﬁcant positive correlations between parameter
estimates for the two sessions were observed, but only for connec-
tions of the pre-SMA: with prefrontal, motor and premotor cortex.
Since the pre-SMA and SMA are especially vulnerable cortical regions
to Parkinson's disease (Haslinger et al., 2001; Jahanshahi et al., 1995;
Playford et al., 1992; Sabatini et al., 2000; Samuel et al., 1997; Yu et al.,
2007) our subjects at different stages of PD will have had a higher
within-group between-subjects variance of pre-SMA/SMA connec-
tivity than healthy control subjects. This high between subjects
variance in pre-SMA function may have increased the signal to noise
for correlations across separate sessions, despite drug treatment in
one session.
Why is the reliability of parameter estimates so poor, and in
contrast to previous studies (Schuyler et al., 2009) and the reliability
of model selection? One important factor is the posterior covariancesamong parameters e.g. if a model allowed one parameter to
compensate for changes in another parameter, maintaining overall
model evidence, then the anti-correlated values of both parameters
could vary widely from session to session. This lack of identiﬁability of
the parameters limits reliability across sessions, affecting both
hemodynamic (Deneux and Faugeras, 2006) and connectivity para-
meters (Stephan et al., 2009b, 2007b) in second level statistical tests
on these parameters (but not model selection). When posterior
covariances among connectivity parameters are expressed as correla-
tions for our preferred model E2 the values seem low (generally 0 to
−0.1; Fig. 6). However, they were consistent across sessions and
across groups.
These posterior covariances will be model speciﬁc, leading to the
possibility that a better model (by model evidence) has worse
reliability of parameter estimates. Within a preferred model, one
could in principle use regularisation of the intrinsic and bilinear
parameters, or re-estimate the models after constraining strongly
covarying parameters. This approach might improve the between
sessions reproducibility of parameter estimates, but it is not yet
developed. Model complexity may inﬂuence the reliability of
parameter estimation. The high reliability reported by Schuyler et
al. (2009) refers to structurally very simple models, with two or three
regions connected by feed-forward only connections. In contrast, our
Bayesian model selection identiﬁed a model of intermediate com-
plexity (E2) which included feed-forward and feed-back connections.
For our study and model, the presence of signiﬁcant posterior
dependencies among parameter estimates is an indication for caution
before using secondary (frequentist) statistics applied to the
parameter estimates.
As within-subject variance sets a minimum variance for between
subjects comparisons, the poor reliability increases the chance of
failing to observe group differences in terms of estimated parameters.
While this does not invalidate previous reports of group effects on
parameter estimates (Passamonti et al., 2008; Rowe et al., 2008b;
Sonty et al., 2007; Summerﬁeld et al., 2006) it does increase the risk of
type II error in future studies. We recommend that if a hypothesis is to
be tested by second level tests on parameters, then the posterior
covariance matrix is inspected closely. For single group studies,
Bayesian parameter averaging (Garrido et al., 2007)may be used as an
alternative, weighting the group's joint posterior distribution by the
precisions of each subject and accounting for the posterior covar-
iances among parameters. For group studies, new methods for
Bayesian Model Averaging are awaited.
There are other possible reasons for the difference between our
reliability estimates and these reported by Schuyler et al. (2009) for
fMRI-based DCM. Both studies used relatively simple sensori-motor
paradigms and conventional data pre-processing. However, the
interval between sessions differed: 5 min for Schuyler et al. (2009)
and weeks for this study. The longer interval may increase differences
in cognitive strategies, haemodynamic properties and neuronal
dynamics within distributed networks.
Another potential confound is differential movement during
sessions, either between groups (e.g. PD versus healthy subjects) or
within subjects (e.g. on- versus off-medication). We used a ‘scan
nulling’ approach with standard thresholds across all subjects
(Lemieux et al., 2007; Rowe et al., 2008b,c) to correct for movements
in ﬁrst level models and time-series extraction. PD patients tended to
make more such movements. However, reliability was poor even
among healthy controls with few signiﬁcant movements.
Model space
If model selection procedures are sufﬁcient and more robust, one
must consider how many models should be compared. The answer
must be theoreticallymotivated for each study, although theremay be
constraints on the upper limit imposed by current technology and
1025J.B. Rowe et al. / NeuroImage 52 (2010) 1015–1026time available to compute and compare a very large set of models. For
example, for our four-node anatomic network and paradigm, there
are approximately 1010 models that could be compared, most of
which are a priori not plausible. Some studies have used a single
model and emphasised the parameterisation within this model
(Summerﬁeld et al., 2006). Typically however, a small set of models,
2bnb15, have been compared in published studies to date. These
models have been chosen not because they enable an exhaustive
search of model space. The model set has been chosen because the
differences between models represent theoretically relevant alterna-
tive hypotheses about which connections are subject to contextual
modulation (Acs and Greenlee, 2008; den Ouden et al., 2009) or the
structure of intrinsic connections including presence or absence of
feedback connections and the roles of direct versus indirect regional
interactions (den Ouden et al., 2009; Fairhall and Ishai, 2007; Stephan
et al., 2007a).
This study used a relatively large set of models in relation to the
published literature (n=48). There were several reasons for using a
larger model set. First, we wished to include a basic model that was
structurally similar to that used for SEM in a previous study, even
though this was likely to be a poor representation of the underlying
network because of the absence of feedback connections. Second, we
wanted to compare models with and without feedback, rather than
assuming only a rostro-caudal cascade of inﬂuence. Third, we wanted
to include perturbation of the PFC by both task and the contextual
moderator in some models. In addition to modulation of downstream
activity by contextual modulation of connectivity, the inputs to the
network via prefrontal cortex might also have been varied between
conditions. Fourth, we wanted to explore the likely sites of contextual
modulation of connectivity, particularly in relation to the functional
roles of the pre-SMA and premotor cortex in Parkinson's disease.
These different objectives necessitated a large set of models. Our
set of models also allowed an empirical assessment of the perfor-
mance of the model complexity term including the free energy
estimate of the log-evidence for each mode. This complexity term is
the Kullback–Leibler divergence between the posterior and prior
density (Friston et al., 2007) that includes the interdependencies
between model parameters. Simply adding more user speciﬁed
parameters e.g. intrinsic or bilinear effects in the model, does not
necessarily improve model goodness, even if the model becomes
more accurate. The model evidence decreases if one makes bad
assumptions about the model structure and parameter distributions.
From Figs. 1 and 2a, it can be seen that more complex sets of models
(sets D and F vs. B) may actually worsen model evidence, and that
even within a model set additional bilinear terms (sets 1 to 6) may
also worsen the overall model evidence, unless of course they
represent the “real” modulatory effects within the generative brain
network.
There are several limitations to our study. We may have lacked
power to detect underlying correlations of connectivity parameters
across sessions. The size of our groups are within the typical range for
classical statistical parametric mapping of regional activations (SPM)
and adequately powered for visuomotor tasks like the one used in this
study (Thirion et al., 2007) (supported for our chosen task by the
concordance over many studies, see Introduction). Although our data
indicate DCM based model selection does re-identify the most likely
model on two occasions in healthy adults, power estimates for DCM
are not yet widely available (Goulden et al., 2009).
Our study used standard BOLD-EPI acquisition sequences and a
commonly used pre-processing pathway for fMRI data intended for
both DCM and classical analysis. fMRI may be confounded by session
effects (McGonigle et al., 2000) due tomany factors including variable
BOLD sensitivity, differential motion artefacts (Lund et al., 2005) and
potential confounds introduced by drug effects on neurovascular
coupling and the BOLD signal (Iannetti andWise, 2007). These factors
may also affect analyses of effective connectivity, including DCM, anddiminish the measured correlations of connectivity parameters over
sessions. However, the subject-speciﬁc and region-speciﬁc estimation
of the parameters of the forward model (from neuronal activity to
BOLD signal) enables a wide variation in the shape and timing of the
evoked haemodynamic response. Moreover, the haemodynamic
parameters deﬁning this forward model remain constant over all
task conditions within a session, such that the approximation to the
true evoked haemodynamic response to neural activity is applicable
to all event types. Therefore, confounding effects of drug and sessional
differences in BOLD might be less for DCM based estimates of
anatomically deﬁned effective connectivity changes driven by
experimental factors, than estimates of whole brain functional
connectivity.
Conclusion
Dynamic Causal Modelling model selection procedures are able to
re-identify the same model as most likely, given independent data
acquired from a group of subjects on 2 separate days. A different
model was identiﬁed as most likely in patients with Parkinson's
disease after medication withdrawal, revealing a switch from amedial
to lateral cortical route for voluntary actions in the frontal lobe. Both
random effects and ﬁxed effects approaches are practical to compare
many models across and between large groups, but model selection
wasmore robust than parameter estimationwithin the optimalmodel
for healthy controls. Our results support the future use of DCM in
clinical and pharmacological fMRI studies.
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